Clinical Trials Browser

Phase 3 × Drug Evaluation × Clear all

NCT05054751 2024-10-10

GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT04197986 2024-03-13

PROOF302

Phase 3 Terminated

39 enrolled 31 charts

Upper Tract Urothelial Carcinomas